The CD47–SIRPα interaction between tumor cells and immune cells represents a critical intercellular communication that inhibits the activation of macrophage-mediated phagocytosis of tumors and thereby acts as a myeloid-specific immune checkpoint (20–23). The gene discussed is SIRPA; the disease is neoplasm.